Comparison of CSF neurofilament light chain, neurogranin, and tau to MRI markers-Reference-Cited by-同舟云学术

Comparison of CSF neurofilament light chain, neurogranin, and tau to MRI markers

Published:2021-03-04 Issue:5 Volume:17 Page:801-812
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Mielke Michelle M.¹²,Przybelski Scott A.¹,Lesnick Timothy G.¹,Kern Silke³,Zetterberg Henrik³⁴⁵⁶,Blennow Kaj³⁴,Knopman David S.²,Graff‐Radford Jonathan²,Petersen Ronald C.¹²,Jack Clifford R.⁷,Vemuri Prashanthi⁷

Affiliation:

1. Department of Health Sciences Research Mayo Clinic Rochester Minnesota USA

2. Department of Neurology Mayo Clinic Rochester Minnesota USA

3. Department of Psychiatry and Neurochemistry Institute of Neuroscience and Physiology The Sahlgrenska Academy at the University of Gothenburg Mölndal Sweden

4. Clinical Neurochemistry Laboratory Sahlgrenska University Hospital Mölndal Sweden

5. Department of Neurodegenerative Disease UCL Institute of Neurology London UK

6. UK Dementia Research Institute at UCL London UK

7. Department of Radiology Mayo Clinic Rochester Minnesota USA

Funder

National Science Foundation

National Institute on Aging

Vetenskapsrådet

H2020 European Research Council

Knut och Alice Wallenbergs Stiftelse

Torsten Söderbergs Stiftelse

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.12239

Reference39 articles.

1. Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

2. Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease

3. Associations of Amyloid, Tau, and Neurodegeneration Biomarker Profiles With Rates of Memory Decline Among Individuals Without Dementia

4. NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease

5. Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial;Nature Medicine;2024-05-17

2. Tau pathology is associated with synaptic density and longitudinal synaptic loss in Alzheimer’s disease;Molecular Psychiatry;2024-04-08

3. Operationalizing selection criteria for clinical trials in Alzheimer's disease: Biomarker and clinical considerations;Alzheimer's & Dementia: Translational Research & Clinical Interventions;2023-10

4. Neurofilaments – Small proteins of physiological significance and predictive power for future neurodegeneration and cognitive decline across the life span;Ageing Research Reviews;2023-09

5. Structural irregularities in MR corpus callosal images and their association with cerebrospinal fluid biomarkers in Mild Cognitive Impairments;Neuroscience Letters;2023-07